Related references
Note: Only part of the references are listed.Development of a Prognostic Model for Overall Survival in Patients With Extracranial Oligometastatic Disease Treated With Stereotactic Body Radiation Therapy
Hanbo Chen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Substituting SABR for systemic therapy in oligometastatic renal cell carcinoma - buying time or time to change?
Shankar Siva et al.
NATURE REVIEWS UROLOGY (2022)
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study
L. Nicosia et al.
RADIOTHERAPY AND ONCOLOGY (2022)
PSMA PET in Imaging Prostate Cancer
Ioannis Tsechelidis et al.
FRONTIERS IN ONCOLOGY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns
Rami A. El Shafie et al.
FRONTIERS IN ONCOLOGY (2020)
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
David A. Palma et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival
Takaya Yamamoto et al.
BMC CANCER (2020)
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Yolande Lievens et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Local treatment of oligometastatic disease: current role
Moritz T. Winkelmann et al.
BRITISH JOURNAL OF RADIOLOGY (2019)
Predictive factors for survival outcomes of oligometastatic prostate cancer patients treated with metastases-directed therapy: a recursive partitioning-based analysis
Ciro Franzese et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report
Anne-Marie C. Dingemans et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Are 90% of deaths from cancer caused by metastases?
Hanna Dillekas et al.
CANCER MEDICINE (2019)
Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy
Aman Sharma et al.
ACTA ONCOLOGICA (2019)
Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation Therapy
Davide Franceschini et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
Piet Ost et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
Theo Ruers et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control
R. J. Klement et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
Theo Ruers et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program CASCADE
Peter Savas et al.
PLOS MEDICINE (2016)
Performance Status in Patients With Cancer Patient performance status (PS) is an important part of cancer care and treatment
Howard (Jack) West et al.
JAMA ONCOLOGY (2015)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)